BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34705081)

  • 1. Revision surgery for chronically discharging mastoid cavities: mastoid obliteration with canal wall reconstruction versus non-obliteration surgery.
    van der Toom HFE; van der Schroeff MP; Molenaar TL; Metselaar M; van Linge A; Vroegop JL; Pauw RJ
    Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):3881-3889. PubMed ID: 34705081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective analysis of hearing after cholesteatoma surgery: the bony obliteration tympanoplasty versus canal wall up and canal wall down without mastoid obliteration.
    van der Toom HFE; van der Schroeff MP; Metselaar M; van Linge A; Vroegop JL; Pauw RJ
    Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5181-5189. PubMed ID: 35399107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful obliteration of troublesome and chronically draining cavities.
    Geerse S; Ebbens FA; de Wolf MJ; van Spronsen E
    J Laryngol Otol; 2017 Feb; 131(2):138-143. PubMed ID: 28069077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative to canal wall-down mastoidectomy for sclerotic mastoid cavities: epitympanoplasty with mastoid obliteration.
    Heo KW; Kang MK; Park JY
    Ann Otol Rhinol Laryngol; 2014 Jan; 123(1):47-52. PubMed ID: 24574423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up results of canal wall down tympanoplasty with mastoid obliteration using the bone pate plate for canal wall reconstruction in cholesteatoma surgery.
    Yamamoto Y; Takahashi K; Morita Y; Ohshima S; Takahashi S
    Otol Neurotol; 2014 Jul; 35(6):961-5. PubMed ID: 24853244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mastoid Obliteration Using Autologous Bone Dust Following Canal Wall Down Mastoidectomy.
    Sioshansi PC; Alyono JC; Blevins NH
    Otol Neurotol; 2021 Jan; 42(1):68-75. PubMed ID: 32976343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial mastoid obliteration combined with soft-wall reconstruction for middle ear cholesteatoma.
    Suzuki H; Ikezaki S; Imazato K; Koizumi H; Ohbuchi T; Hohchi N; Hashida K
    Ann Otol Rhinol Laryngol; 2014 Aug; 123(8):571-5. PubMed ID: 24634153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canal reconstruction mastoidectomy: Outcomes comparison following primary versus secondary surgery.
    Stevens SM; Walters ZA; Babo K; Peddireddy N; Tawfik KO; Samy RN
    Laryngoscope; 2019 Nov; 129(11):2580-2587. PubMed ID: 30883762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Treatment for Troublesome Mastoid Cavities: Canal Wall Reconstruction With Bony Obliteration Versus Subtotal Petrosectomy.
    Kemps G; Geven L; Kunst H; Mylanus E; Mulder J; Lanting C; Pennings R
    Otol Neurotol; 2024 Mar; 45(3):273-280. PubMed ID: 38270225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mastoid obliteration combined with soft-wall reconstruction of posterior ear canal.
    Takahashi H; Iwanaga T; Kaieda S; Fukuda T; Kumagami H; Takasaki K; Hasebe S; Funabiki K
    Eur Arch Otorhinolaryngol; 2007 Aug; 264(8):867-71. PubMed ID: 17340129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactive glass obliteration of the mastoid significantly improves surgical outcome in non-cholesteatomatous chronic otitis media patients.
    Vos J; de Vey Mestdagh P; Colnot D; Borggreven P; Orelio C; Quak J
    Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4121-4126. PubMed ID: 28956143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative findings of revision canal wall-down tympanomastoid surgery.
    Kasenõmm P
    Acta Otolaryngol; 2013 Aug; 133(8):826-32. PubMed ID: 23848263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Obliteration in the Achievement of a Dry Mastoid Bowl.
    Harun A; Clark J; Semenov YR; Francis HW
    Otol Neurotol; 2015 Sep; 36(9):1510-7. PubMed ID: 26375974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of canal wall reconstruction tympanomastoidectomy.
    Walker PC; Mowry SE; Hansen MR; Gantz BJ
    Otol Neurotol; 2014 Jul; 35(6):954-60. PubMed ID: 25072070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of canal wall reconstruction tympanomastoidectomy.
    Walker PC; Mowry SE; Hansen MR; Gantz BJ
    Otol Neurotol; 2014 Jan; 35(1):e24-30. PubMed ID: 24136324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mastoid obliteration versus canal wall down or canal wall up mastoidectomy for cholesteatoma: Systematic review and meta-analysis.
    Salem J; Bakundukize J; Milinis K; Sharma SD
    Am J Otolaryngol; 2023; 44(2):103751. PubMed ID: 36586321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Revisional radical mastoidectomy surgeries--25 cases'experience].
    Li L; Xie J; Liu Y; Gong SS
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Oct; 52(10):766-770. PubMed ID: 29050095
    [No Abstract]   [Full Text] [Related]  

  • 18. Results of revision mastoidectomy.
    Berçin S; Kutluhan A; Bozdemir K; Yalçiner G; Sari N; Karamese O
    Acta Otolaryngol; 2009 Feb; 129(2):138-41. PubMed ID: 18607914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mastoid obliteration with S53P4 bioactive glass after canal wall down mastoidectomy: Preliminary results.
    Król B; Cywka KB; Skarżyńska MB; Skarżyński PH
    Am J Otolaryngol; 2021; 42(2):102895. PubMed ID: 33429176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A technique for concurrent procedure of mastoid obliteration and meatoplasty after canal wall down mastoidectomy.
    Kim CW; Oh JI; Choi KY; Park SM; Park MI
    Auris Nasus Larynx; 2012 Dec; 39(6):557-61. PubMed ID: 22321811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.